FITC Anti-Human CD19 Antibody[4G7]

The FITC Anti-Human CD19 Antibody[4G7] is a highly specific and sensitive monoclonal antibody that has been designed for use in a variety of research applications. This antibody is specifically designed to target the CD19 antigen, which is a cell surface protein that is expressed on the majority of B cells. The FITC Anti-Human CD19 Antibody[4G7] is conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of CD19-expressing cells.

This antibody has been extensively tested and validated for use in flow cytometry, immunofluorescence, and immunohistochemistry applications. It has been shown to be highly specific for CD19, with minimal cross-reactivity with other antigens. The FITC Anti-Human CD19 Antibody[4G7] has also been shown to be highly sensitive, with the ability to detect low levels of CD19 expression.

The FITC Anti-Human CD19 Antibody[4G7] is supplied in a convenient format, with a concentration of 0.5 mg/ml. It is provided in a buffer solution that contains stabilizing agents to ensure optimal performance and stability. This antibody is suitable for use in a variety of research applications, including the study of B cell development, differentiation, and activation.

Overall, the FITC Anti-Human CD19 Antibody[4G7] is a highly reliable and effective tool for the detection and analysis of CD19-expressing cells. Its high specificity and sensitivity make it an ideal choice for a wide range of research applications.